Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription

Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 69 articles:
HTML format

Single Articles

    April 2023
  1. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed     Abstract available

    December 2022
  2. BLANDING W, Kilic A
    Demise of HVAD: The only constant is change.
    J Thorac Cardiovasc Surg. 2022;164:1945-1947.

  3. BOSSERS GPL, Gunthel M, van der Feen DE, Hagdorn QAJ, et al
    Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load.
    J Thorac Cardiovasc Surg. 2022;164:e493-e510.
    PubMed     Abstract available

  4. BALACHANDRAN I, Frazier OH, Rogers JG
    Doing the wrong thing for the right reasons: The demise of the HVAD.
    J Thorac Cardiovasc Surg. 2022;164:1937-1941.

    Commentary: Collateral impact of the HVAD decision and the path forward.
    J Thorac Cardiovasc Surg. 2022;164:1942-1943.

  6. BROWN JA, Aranda-Michel E, Kilic A, Serna-Gallegos D, et al
    The impact of pulmonary artery catheter use in cardiac surgery.
    J Thorac Cardiovasc Surg. 2022;164:1965-1973.
    PubMed     Abstract available

  7. FARSKY PS, White J, Al-Khalidi HR, Sueta CA, et al
    Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
    J Thorac Cardiovasc Surg. 2022;164:1890-1899.
    PubMed     Abstract available

  8. HRYTSYNA Y, Kneissler S, Kaufmann F, Muller M, et al
    Experience with a standardized protocol to predict successful explantation of left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1922-1930.
    PubMed     Abstract available

  9. JAWAD K, Sipahi F, Koziarz A, Huhn S, et al
    Less-invasive ventricular assist device implantation: A multicenter study.
    J Thorac Cardiovasc Surg. 2022;164:1910-1918.
    PubMed     Abstract available

  10. BROWN JA, Sultan I
    Commentary: Sometimes less is more: The minimally invasive argument for ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;164:1920-1921.

    November 2022
  11. BLANDING WM, Kilic A
    Commentary: Durable left ventricular assist device infections: A call to arms.
    J Thorac Cardiovasc Surg. 2022;164:1570-1571.

  12. LIKOSKY DS, Yang G, Zhang M, Malani PN, et al
    Interhospital variability in health care-associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries.
    J Thorac Cardiovasc Surg. 2022;164:1561-1568.
    PubMed     Abstract available

    October 2022
  13. HAYWARD C, Adachi I, Baudart S, Davis E, et al
    Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.
    J Thorac Cardiovasc Surg. 2022;164:1120-1137.
    PubMed     Abstract available

  14. GOUTALLIER CS, Buratto E, Schulz A, Hu T, et al
    Repair of complete atrioventricular septal defect between 2 and 3.5 kilograms: Defining the limits of safe repair.
    J Thorac Cardiovasc Surg. 2022;164:1167-1175.
    PubMed     Abstract available

  15. TOMINAGA Y, Taira M, Watanabe T, Hasegawa M, et al
    Clinical significance of diastolic dysfunction on outcomes of pulmonary valve replacement for pulmonary insufficiency.
    J Thorac Cardiovasc Surg. 2022;164:1156-1164.
    PubMed     Abstract available

  16. TOSO A, Castelvecchio S, Menicanti L, Volpe M, et al
    Prognostic value of natriuretic peptides and restrictive filling pattern before surgical ventricular restoration.
    J Thorac Cardiovasc Surg. 2022;164:1092-1101.
    PubMed     Abstract available

    September 2022
  17. SHAH AS
    Commentary: When a ventricular assist device is just not enough.
    J Thorac Cardiovasc Surg. 2022;164:978.

    August 2022
  18. BEDZRA EKS, Adachi I, Peng DM, Amdani S, et al
    Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs Databases.
    J Thorac Cardiovasc Surg. 2022;164:353-364.
    PubMed     Abstract available

    June 2022
  19. SALERNO CT, Hayward C, Hall S, Goldstein D, et al
    HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
    J Thorac Cardiovasc Surg. 2022;163:2120-2127.
    PubMed     Abstract available

  20. SHAFII A, Liao K, Ghanta RK
    Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall.
    J Thorac Cardiovasc Surg. 2022;163:2129-2130.

  21. DEO SV, Sundaram V, Wilson B, Sahadevan J, et al
    Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database.
    J Thorac Cardiovasc Surg. 2022;163:2096-2103.
    PubMed     Abstract available

    April 2022
  22. GAUDINO M, Castelvecchio S, Rahouma M, Robinson NB, et al
    Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial.
    J Thorac Cardiovasc Surg. 2022 Apr 26. pii: S0022-5223(22)00493.
    PubMed     Abstract available

  23. MAH KE, Morales DLS
    Commentary: The Vulcan mind MELD-XI.
    J Thorac Cardiovasc Surg. 2022;163:1477-1478.

    February 2022
  24. ZHU Y, Shudo Y, Lingala B, Baiocchi M, et al
    Outcomes after heart retransplantation: A 50-year single-center experience.
    J Thorac Cardiovasc Surg. 2022;163:712-720.
    PubMed     Abstract available

    January 2022
    Commentary: Heart transplantation listing for children with significant renal insufficiency: The need for a paradigm shift.
    J Thorac Cardiovasc Surg. 2022 Jan 8. pii: S0022-5223(22)00006.

  26. NIKOLOVA A, Youn JC, Kobashigawa JA
    Commentary: The anticlimax of the left ventricular assist devices-associated antibodies.
    J Thorac Cardiovasc Surg. 2022;163:136-137.

  27. BAKIR NH, Finnan MJ, MacGregor RM, Schilling JD, et al
    Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2022;163:124-134.
    PubMed     Abstract available

    November 2021
  28. ELGHARABLY H, Ibrahim A, Rosinski B, Thuita L, et al
    Right heart failure and patient selection for isolated tricuspid valve surgery.
    J Thorac Cardiovasc Surg. 2021 Nov 25. pii: S0022-5223(21)01657.
    PubMed     Abstract available

    Commentary: Preventive treatment of right-sided heart failure before adulthood?
    J Thorac Cardiovasc Surg. 2021 Nov 4. pii: S0022-5223(21)01533.

  30. LI S, Zimpfer D, Mahr C
    Commentary: Transcending acceptable, moving toward optimal: Standardizing surgical configurations of ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:1566-1567.

  31. KASINPILA P, Kong S, Fong R, Shad R, et al
    Use of patient-specific computational models for optimization of aortic insufficiency after implantation of left ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:1556-1563.
    PubMed     Abstract available

    October 2021
  32. YANG B, Caceres J, Farhat L, Le T, et al
    Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes.
    J Thorac Cardiovasc Surg. 2021;162:1049-1059.
    PubMed     Abstract available

    September 2021
  33. RAJAGOPAL K, Cheema FH, Omer S
    Commentary: Heart failure and the problem of causality.
    J Thorac Cardiovasc Surg. 2021 Sep 8. pii: S0022-5223(21)01300.

    August 2021
  34. PERRY T, Morales DLS
    Commentary: Promise with pulsatility? Early bridging of high-risk patients with single-ventricle physiology with a ventricular assist device.
    J Thorac Cardiovasc Surg. 2021;162:415-416.

    Commentary: Better pumps, better patients, better physicians? Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:612-613.

  36. MOON J, Adachi I
    Commentary: Ventricular assist device support in an early infancy with single ventricle: Transformation from salvage to elective.
    J Thorac Cardiovasc Surg. 2021;162:416-417.

  37. LEE MM, Honjo O
    Commentary: How to VAD to avoid BAD in high-risk single ventricle.
    J Thorac Cardiovasc Surg. 2021;162:414-415.

    Commentary: Managing the native heart in patients supported with durable left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2021;162:613-614.

  39. KILIC A
    Commentary: Left ventricular assist device therapy: The time is now.
    J Thorac Cardiovasc Surg. 2021;162:614-615.

  40. DESHPANDE S, Alsoufi B
    Meeting needs-pushing boundaries: Mechanical circulatory support in children; year in review.
    J Thorac Cardiovasc Surg. 2021;162:400-404.

  41. SHAFFER A, Cogswell R, John R
    Future developments in left ventricular assist device therapy.
    J Thorac Cardiovasc Surg. 2021;162:605-611.

    July 2021
    Commentary: Mitochondrial transplantation for myocardial failure, marvel remedy or wishful thinking?
    J Thorac Cardiovasc Surg. 2021;162:e125-e126.

  43. ATLURI P, Balsam LB
    Invited Expert Opinion papers on mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021;162:140-142.

    June 2021
  44. LEE SH, Choi KH, Song YB, Jeong DS, et al
    Comprehensive assessment of heart failure in patients with preserved ejection fraction undergoing coronary bypass grafting.
    J Thorac Cardiovasc Surg. 2021 Jun 19. pii: S0022-5223(21)00980.
    PubMed     Abstract available

  45. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.

  46. BENAZZO A, Bajorek L, Morscher A, Schrutka L, et al
    Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 1. pii: S0022-5223(21)00879.
    PubMed     Abstract available

    May 2021
  47. DESHPANDE S, Sparks JD, Alsoufi B
    Pediatric heart transplantation: Year in review 2020.
    J Thorac Cardiovasc Surg. 2021 May 3. pii: S0022-5223(21)00758.

    April 2021
  48. BAKAEEN FG, Gaudino M, Whitman G, Doenst T, et al
    2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.
    J Thorac Cardiovasc Surg. 2021 Apr 30. pii: S0022-5223(21)00736.

  49. TIMEK TA
    Commentary: The pneumatic para-trouper.
    J Thorac Cardiovasc Surg. 2021;161:1467-1468.

  50. VILLA CR, Morales DLS
    Commentary: Rejuvenation of a trusted tool.
    J Thorac Cardiovasc Surg. 2021;161:1466-1467.

    Commentary: Adult support with a pulsatile VAD: Reawakening of a bygone era?
    J Thorac Cardiovasc Surg. 2021;161:1465-1466.

    March 2021
    Commentary: Benefits of SGLT2 inhibition in heart failure: A bellwether for importance of other metabolic pathways.
    J Thorac Cardiovasc Surg. 2021 Mar 27. pii: S0022-5223(21)00554.

  53. AMBROSIO G, Mattioli R, Carluccio E
    Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism.
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00416.

  54. LAZAR HL
    Commentary: SGLT2 inhibitors reduce mortality and heart failure in patients with type 2 diabetes mellitus-is metabolic reprogramming the mechanism for these favorable outcomes?
    J Thorac Cardiovasc Surg. 2021 Mar 5. pii: S0022-5223(21)00415.

  55. MANN PA, Lehrke M
    Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition?
    J Thorac Cardiovasc Surg. 2021 Mar 3. pii: S0022-5223(21)00410.

    February 2021
  56. CASTELVECCHIO S, Frigelli M, Sturla F, Milani V, et al
    Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: A 3-dimensional ultrasound analysis.
    J Thorac Cardiovasc Surg. 2021 Feb 26. pii: S0022-5223(21)00381.
    PubMed     Abstract available

    Commentary: To fix or not to fix? That is the question for mitral and aortic valve surgery during left ventricular assist devices implantation.
    J Thorac Cardiovasc Surg. 2021 Feb 18. pii: S0022-5223(21)00344.

  58. MELEHY A, Sanchez JE, Nemeth SK, Kurlansky PA, et al
    National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2021 Feb 5. pii: S0022-5223(21)00213.
    PubMed     Abstract available

    January 2021
  59. HAWKINS RB, Mehaffey JH
    Commentary: Is heart failure with moderately reduced ejection fraction a useful classification for cardiac surgery?
    J Thorac Cardiovasc Surg. 2021 Jan 29. pii: S0022-5223(21)00179.

  60. DEO SV, Sundaram V, Sahadevan J, Selvaganesan P, et al
    Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    J Thorac Cardiovasc Surg. 2021 Jan 23. pii: S0022-5223(21)00132.
    PubMed     Abstract available

    December 2020
  61. HIRJI SA, Cote CL, Javadikasgari H, Malarczyk A, et al
    Atrial functional versus ventricular functional mitral regurgitation: Prognostic implications.
    J Thorac Cardiovasc Surg. 2020 Dec 31. pii: S0022-5223(20)33453.
    PubMed     Abstract available

  62. TANAKA Y, Nakajima T, Fischer I, Wan F, et al
    The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.
    J Thorac Cardiovasc Surg. 2020;160:1490-1500.
    PubMed     Abstract available

    November 2020
  63. RIGGS KW, Morales DLS, Zafar F
    Commentary: Is two ever better than one in pediatric ventricular assist device support? The controversy continues.
    J Thorac Cardiovasc Surg. 2020;160:1309-1310.

    September 2020
    Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.
    J Thorac Cardiovasc Surg. 2020 Sep 9. pii: S0022-5223(20)32581.

    Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19).
    J Thorac Cardiovasc Surg. 2020 Sep 4. pii: S0022-5223(20)32567.

  66. ONOHARA D, Corporan DM, Kono T, Kumar S, et al
    Ventricular reshaping with a beating heart implant improves pump function in experimental heart failure.
    J Thorac Cardiovasc Surg. 2020 Sep 3. pii: S0022-5223(20)32535.
    PubMed     Abstract available

  67. BANSAL A, Goldstein D, Schettle S, Pepitone S, et al
    Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic.
    J Thorac Cardiovasc Surg. 2020 Sep 2. pii: S0022-5223(20)32490.

    July 2020
    Commentary: Absence of ventricular assist device-related risk for rejection after heart transplantation: Good news given the "new normal".
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32053.

    February 2020
  69. SILVER SA, Long J, Zheng Y, Goldstone AB, et al
    Outcomes after left ventricular assist device implantation in patients with acute kidney injury.
    J Thorac Cardiovasc Surg. 2020;159:477-486.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.